Boehringer pharma chief heads for the exit amid a top-level reshuffling

27th August 2019 Uncategorised 0

Boehringer Ingelheim has made a concerted push to boost its pipeline with a suite of recent acquisitions. Now, the company’s shuffling senior management—and its board—as its top pharma exec heads for the exit.

More: Boehringer pharma chief heads for the exit amid a top-level reshuffling
Source: fierce